New research is providing more evidence and understanding about the effectiveness and safety of tirzepatide versus semaglutide.
What is the latest evidence for the management of patients with obesity?
In this webcast on 27 May, Associate Professor Samantha Hocking provides an update on the latest study and what it means for prescribing clinicians who are using these agents as part of their management of patients with obesity.
How do the CPD options work?
- Attend the webcast and earn 2 hrs CPD in the Educational Activities category by attending the webcast lecture and completing the evaluation (RACGP & ACRRM approved)
- Complete the optional post-webcast quiz and earn 0.5 hrs CPD in the Reviewing Performance category (RACGP & ACRRM approved)
- Complete the optional Patient Case Review and earn a further 0.5 hrs CPD in the Reviewing Performance category (RACGP & ACRRM approved)
- Undertake the optional Micro Audit and gain 1 hrs CPD in the Measuring Outcomes category (RACGP & ACRRM approved)
Other professions can self-claim up to 4 hrs CPD.
Attendees will receive Certificate of Attendance about two weeks post-webcast.
Don’t miss out, REGISTER NOW.
Topics include:
Winter Virus Preparations
Prof Paul Griffin – Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland
Winter is almost here and once again we are expecting new strains of flu and other respiratory viruses to cause widespread misery and morbidity.
In this talk, infectious diseases expert Professor Paul Griffin will provide an update on which viruses are currently causing disease and which are predicted to pose a threat this winter. He will also discuss the latest recommendations in terms of vaccinations and target populations, as well as advising how best to manage some of the challenges faced by clinicians advocating immunisation.
Genitourinary Syndrome of Menopause – Mythbusting for GPs
A/Prof Gino Pecoraro OAM – Obstetrician and Gynaecologist, Wesley Maternity Hospital; Senior Clinical Lecturer in Obstetrics & Gynaecology, University of QLD
Genitourinary syndrome of menopause (previously known as vulvovaginal atrophy) affects as many as half of all women post-menopause and, without treatment, can cause significant discomfort, distress and diminished quality of life.
In this webcast, Associate Professor Gino Pecoraro will discuss the prevalence and pathophysiology of this condition as well as providing the latest, evidence based recommendations for its treatment. Importantly, he will also be talking about commonly-advertised therapies that have no evidence of effectiveness, and some that have actually been shown not to work.
Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence
A/Prof Sam Hocking – Endocrinologist; Royal Prince Alfred Hospital; Clinical Academic at Charles Perkins Research Centre, University of Sydney; President, National Association of Clinical Obesity Services (NACOS)
New research is providing more evidence and understanding about the effectiveness and safety of tirzepatide versus semaglutide.
Hear from Associate Professor Samantha Hocking about this latest study and what it means for prescribing clinicians who are using these agents as part of their management of patients with obesity.
Dysmenorrhoea in Teens
Prof Sonia Grover – Gynaecologist and Pain Medicine Specialist; The Royal Children’s Hospital Melbourne; Murdoch Children’s Research Institute
If periods are interfering with the teenager’s life and causing distress, treatment is needed. In this talk, Professor Sonia Grover shares her clinical expertise and real-world experience about the best way to assess and manage adolescent girls who present with heavy and/or painful periods. She will also highlight the importance of recognising and treating these patients early to, not only improve their quality of life at the time but also improve their long-term health outcomes including their long-term fertility.
Date:
Tuesday 27th May 2025
Time:
7pm – 9pm AEST (NSW, VIC, TAS, ACT, QLD)
6:30pm – 8:30pm ACDT (SA, NT)
5pm – 7pm AWST (WA)
